Long double-stranded RNA-mediated RNA interference and immunostimulation: Long interfering double-stranded RNA as a potent anticancer therapeutics

Nucleic Acid Therapeutics

Volumn 21, Issue 3, 2011, Pages 149-155

  Chang, Chan Ii ^a,b   Lee, Tae Yeon ^a   Dua, Pooja ^a,c   Kim, Soyoun ^c   Li, Chiang J ^b   Lee, Dong Ki ^a  

^a Sungkyunkwan University   (South Korea)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Dongguk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DOUBLE STRANDED DNA; DOUBLE STRANDED RNA; LONG INTERFERING DOUBLE STRANDED RNA; MESSENGER RNA; SURVIVIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER THERAPY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; PRIORITY JOURNAL; RNA INTERFERENCE; RNA STRUCTURE;

2-AMINOPURINE; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; EIF-2 KINASE; GENE EXPRESSION; HELA CELLS; HUMANS; IMMUNIZATION; INHIBITOR OF APOPTOSIS PROTEINS; INTERFERON-BETA; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NEOPLASMS; RNA INTERFERENCE; RNA, DOUBLE-STRANDED;

EID: 80052158135     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2011.0296     Document Type: Article

References (22)

1. CHANG, C.I., KANG, H.S., BAN, C., KIM, S., and LEE, D.K. (2009a). Dual-target gene silencing by using long, synthetic siRNA duplexes without triggering antiviral responses. Mol. Cells 27, 689-695.
2. CHANG, C.I., YOO, J.W., HONG, S.W., LEE, S.E., KANG, H.S., SUN, X., ROGOFF, H.A., BAN, C., KIM, S., LI, C.J., and LEE, D.K. (2009b). Asymmetric shorter-duplex siRNA structures trigger efficient gene silencing with reduced nonspecific effects. Mol. Ther. 17, 725-732.
3. CHOWDHURY, E.H. (2011). Strategies for tumor-directed delivery of siRNA. Expert Opin. Drug Deliv. 8, 389-401.
4. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K., and TUSCHL, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498. (Pubitemid 32494397)
5. FIRE, A., XU, S., MONTGOMERY, M.K., KOSTAS, S.A., DRIVER, S.E., and MELLO, C.C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811. (Pubitemid 28099681)
6. FRIEDRICH, I., EIZENBACH, M., SAJMAN, J., BEN-BASSAT, H., and LEVITZKI, A. (2005). A cellular screening assay to test the ability of PKR to induce cell death in mammalian cells. Mol. Ther. 12, 969-975. (Pubitemid 41614493)
7. FRIEDRICH, I., SHIR, A., KLEIN, S., and LEVITZKI, A. (2004). RNA molecules as anti-cancer agents. Semin. Cancer Biol. 14, 223-230. (Pubitemid 38824583)
8. GANTIER, M.P., TONG, S., BEHLKE, M.A., IRVING, A.T., LAPPAS, M., NILSSON, U.W., LATZ, E., MCMILLAN, N.A., and WILLIAMS, B.R. (2010). Rational design of im-munostimulatory siRNAs. Mol. Ther. 18, 785-795.
9. GANTIER, M.P., and WILLIAMS, B.R. (2007). The response of mammalian cells to double-stranded RNA. Cytokine Growth Factor Rev. 18, 363-371. (Pubitemid 47302837)
10. GIL, J., ALCAMI, J., and ESTEBAN, M. (1999). Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. Mol. Cell. Biol. 19, 4653-4663. (Pubitemid 29289503)
11. HANNON, G.J. (2002). RNA interference. Nature 418, 244-251. (Pubitemid 34773784)
12. IORDANOV, M.S., WONG, J., BELL, J.C., and MAGUN, B.E. (2001). Activation of NF-kappaB by double-stranded RNA (dsRNA) in the absence of protein kinase R and RNase L demonstrates the existence of two separate dsRNA-triggered antiviral programs. Mol. Cell. Biol. 21, 61-72.
13. PECOT, C.V., CALIN, G.A., COLEMAN, R.L., LOPEZ-BERESTEIN, G., and SOOD, A.K. (2010). RNA interference in the clinic: challenges and future directions. Nat. Rev. Cancer 11, 59-67.
14. POECK, H., BESCH, R., MAIHOEFER, C., RENN, M., TORMO, D., MORSKAYA, S.S., KIRSCHNEK, S., GAFFAL, E., LANDSBERG, J., HELLMUTH, J., SCHMIDT, A., ANZ, D., BSCHEIDER, M., SCHWERD, T., BERKING, C., BOURQUIN, C., KALINKE, U., KREMMER, E., KATO, H., AKIRA, S., MEYERS, R., HACKER, G., NEUENHAHN, M., BUSCH, D., RULAND, J., ROTHENFUSSER, S., PRINZ, M., HORNUNG, V., ENDRES, S., TUTING, T., and HARTMANN, G. (2008). 5′-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma. Nat. Med. 14, 1256-1263.
15. RYAN, B.M., O'DONOVAN, N., and DUFFY, M.J. (2009). Sur-vivin: a new target for anti-cancer therapy. Cancer Treat. Rev. 35, 553-562.
16. SCHAFFERT, D., KISS, M., RODL, W., SHIR, A., LEVITZKI, A., OGRIS, M., and WAGNER, E. (2011). Poly(I:C)-mediated tu-mor growth suppression in EGF-receptor overexpressing tumors using EGF-polyethylene glycol-linear polyethylenimine as carrier. Pharm. Res. 28, 731-741.
17. SCHLEE, M., HORNUNG, V., and HARTMANN, G. (2006). siRNA and isRNA: two edges of one sword. Mol. Ther. 14, 463-470. (Pubitemid 44296098)
18. SHIR, A., and LEVITZKI, A. (2002). Inhibition of glioma growth by tumor-specific activation of double-stranded RNA-dependent protein kinase PKR. Nat. Biotechnol. 20, 895-900. (Pubitemid 35001126)
19. SHIR, A., OGRIS, M., WAGNER, E., and LEVITZKI, A. (2006). EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice. PLoS Med. 3, e6.
20. STARK, G.R., KERR, I.M., WILLIAMS, B.R., SILVERMAN, R.H., and SCHREIBER, R.D. (1998). How cells respond to interfer-ons. Annu. Rev. Biochem. 67, 227-264.
21. VENKATARAMAN, S., DIRKS, R.M., UEDA, C.T., and PIERCE, N.A. (2010). Selective cell death mediated by small conditional RNAs. Proc. Natl. Acad. Sci. U. S. A. 107, 16777-16782.
22. WEIL, R.J. (2006). Glioblastoma multiforme-treating a deadly tumor with both strands of RNA. PLoS Med 3, e31.